Cargando…

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

Interleukin 6 and C-reactive protein (CRP) were determined prior to IL-2 therapy in sera from metastatic melanoma patients. Patients with elevated serum IL-6 (> 20 pg ml-1) and/or CRP (> 10 mg l-1) levels were associated with resistance to IL-2 therapy. A correlation between high serum IL-6 le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tartour, E., Dorval, T., Mosseri, V., Deneux, L., Mathiot, C., Brailly, H., Montero, F., Joyeux, I., Pouillart, P., Fridman, W. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968905/ https://www.ncbi.nlm.nih.gov/pubmed/8180022

Ejemplares similares

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings
por: Tartour, E, et al.
Publicado: (2000)

Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
por: des Guetz, Gaetan, et al.
Publicado: (2009)

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer.
por: Scholl, S. M., et al.
Publicado: (1994)

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
por: Laino, Andressa S, et al.
Publicado: (2020)

Serum Levels of Interleukin 10 (IL-10) in Patients with Type 2 Diabetes
por: Yaghini, N, et al.
Publicado: (2011)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease
por: Bishnoi, Ram J., et al.
Publicado: (2015)

IL8 and Cathepsin B as Melanoma Serum Biomarkers
por: Zhang, Hongtao, et al.
Publicado: (2011)

Similar biological effects of different low doses of interferon alpha in cancer patients.
por: Billard, C., et al.
Publicado: (1987)

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis
por: Lin, Emily, et al.
Publicado: (2019)

Effect of topical application of melatonin on serum levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in patients with type 1 or type 2 diabetes and periodontal disease
por: Cutando, Antonio, et al.
Publicado: (2015)

Interleukin 32 expression in human melanoma
por: Paz, Helicia, et al.
Publicado: (2019)

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma
por: Wang, Hua, et al.
Publicado: (2016)

Interleukins in the treatment of melanoma
por: Xu, Xinyuan, et al.
Publicado: (2022)

Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas
por: Zhang, Yan, et al.
Publicado: (2020)

Complete metastasectomy after high-dose interleukin-2 (HD IL-2) therapy for melanoma
por: Chu, Melinda, et al.
Publicado: (2015)

Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients
por: Emami Ardestani, Mohammad, et al.
Publicado: (2015)

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

The Role of Interleukin-1 cytokine family (IL-1β, IL-37) and interleukin-12 cytokine family (IL-12, IL-35) in eumycetoma infection pathogenesis
por: Abushouk, Amir, et al.
Publicado: (2019)

Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma
por: Ham, Jun Soo, et al.
Publicado: (2017)

IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
por: Tobin, Richard P., et al.
Publicado: (2019)

Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells
por: Yao, Yongxue, et al.
Publicado: (2005)

Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis
por: FİLİZ, Başak, et al.
Publicado: (2019)

Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata()()
por: Aşkın, Özge, et al.
Publicado: (2021)

Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure
por: Yu, Xueping, et al.
Publicado: (2016)

Increased levels of serum interleukin-10 are associated with poor outcome in adult hemophagocytic lymphohistiocytosis patients
por: Zhou, Yulan, et al.
Publicado: (2021)

Las actividades físicas y deportivas : enseñar, estimular, entrenar /
por: Pouillart, G.
Publicado: (1989)

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
por: Buchbinder, Elizabeth I., et al.
Publicado: (2016)

Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients
por: Mirjačić Martinović, Katarina, et al.
Publicado: (2023)

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study.
por: Thatcher, N., et al.
Publicado: (1989)

Prognosis value of IL-6, IL-8, and IL-1β in serum of patients with lung cancer: A fresh look at interleukins as a biomarker
por: Yan, Xi, et al.
Publicado: (2022)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study.
por: Thatcher, N., et al.
Publicado: (1990)

Upregulation of Serum miR-10b Is Associated with Poor Prognosis in Patients with Melanoma
por: Bai, Ming, et al.
Publicado: (2017)

Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer
por: Hou, Yongwang, et al.
Publicado: (2022)

The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
por: Borazan, Ali, et al.
Publicado: (2004)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

Peripheral Blood Leukocytes Interleukin-1 Beta (IL-1β) Cytokine Hyper-Reactivity in Chronic Periodontitis
por: Sakalauskiene, Jurgina, et al.
Publicado: (2016)

Role of Serum Interleukin-6 and C-reactive Protein in Early Prediction of Severe Acute Pancreatitis
por: Kumar, Ram Bharosh, et al.
Publicado: (2022)

Expression of interleukin 10 in human melanoma.
por: Krüger-Krasagakes, S., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_ust723r5glhh5t7svasgl9tdd1